Free tool
FAERS Monitor: Oraverse
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022159 or its brand name (Oraverse, Phentolamine Mesylate). Reports on generic versions are filed under their own applications.
Reports
112
Serious
89
79% of reports
Hospitalization
45
Death reported
11
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- blood urea increased14
- blood glucose increased13
- neutrophil count increased13
- anaemia12
- diarrhoea12
- lymphocyte count decreased12
- hypertension11
- dizziness10
- haemoglobin decreased10
- abdominal distension9
- hypoaesthesia9
- pyrexia9
- dyspnoea8
- platelet count decreased8
- abdominal sepsis7
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2007 | 6 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 15 |
| 2012 | 6 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 20 |
| 2018 | 9 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 3 |
| 2025 | 4 |
| 2026 | 5 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,047 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| abdominal sepsisSignal | 7 | 1505.6 | 732.6 | 9,003 |
| neutrophil count increasedSignal | 13 | 238.7 | 143.2 | 2,842 |
| blood urea increasedSignal | 14 | 157.2 | 96.3 | 2,019 |
| lymphocyte count decreasedSignal | 12 | 127.6 | 74.7 | 1,383 |
| haemoglobin decreasedSignal | 10 | 18.3 | 10.1 | 147 |
| abdominal distensionSignal | 9 | 16.2 | 8.7 | 114 |
| platelet count decreasedSignal | 8 | 14.1 | 7.2 | 85 |
| blood glucose increasedSignal | 13 | 13.0 | 7.8 | 133 |
| anaemiaSignal | 12 | 11.8 | 6.9 | 109 |
| hypoaesthesiaSignal | 9 | 11.3 | 6.0 | 75 |
| hypertensionSignal | 11 | 9.8 | 5.6 | 79 |
| pyrexiaSignal | 9 | 4.9 | 2.6 | 24 |
| dizzinessSignal | 10 | 3.8 | 2.1 | 18 |
| diarrhoeaSignal | 12 | 3.5 | 2.0 | 20 |
| dyspnoeaSignal | 8 | 2.7 | 1.4 | 7 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.